PG

• Fourth quarter diluted EPS decreased 15% to $1.26; core EPS decreased 3% to $1.43.
• Fiscal year 2026 net sales were $87.0 billion, up 3%; diluted EPS increased 2% to $6.62; core EPS increased 1% to $6.89.
• Fiscal 2027 guidance: all-in sales growth 1-3%, organic sales growth 1-3%, diluted EPS growth 1-5%, core EPS growth in-line to 3% (range $6.89-$7.11).
• Company returned over $15 billion to shareholders in fiscal 2026, including $10.2 billion in dividends and $5.0 billion in share repurchases.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Shailesh G. Jejurikar, President and CEO, appointed Chairman of the Board effective August 1, 2026, in addition to his current roles.
• Joseph Jimenez was reappointed as the Board's independent Lead Director.
• The changes were announced in a July 29, 2026 news release furnished as Exhibit 99.1.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• Q4 FY 2026 organic sales were flat, core EPS declined 3%, and adjusted free cash flow productivity was 133%.
• FY 2027 guidance includes organic sales growth of +1% to +3%, core EPS growth of +0% to +3%, and all-in EPS growth of +1% to +5%.
• The company cited headwinds including a $1 billion after-tax impact from higher energy, transportation, and raw material costs, and a $50 million after-tax FX headwind.
• The filing was made under Item 7.01 Regulation FD Disclosure, furnishing slides used in the earnings conference call.

7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• The dividend is payable on or after August 17, 2026, to shareholders of record at the close of business on July 24, 2026 (Common Stock) and at the start of business on July 24, 2026 (Preferred Stock).
• The announcement was made via a news release dated July 14, 2026, furnished as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure.
• P&G has paid a dividend for 136 consecutive years and has increased its dividend for 70 consecutive years.

7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• Organic sales increased 3% year-over-year, driven by 2% volume growth and 1% higher pricing.
• Diluted EPS was $1.63, up 6%, and Core EPS was $1.59, up 3%.
• The company maintained fiscal 2026 guidance for all-in sales growth of 1-5% and organic sales growth of in-line to up 4%.
• P&G expects fiscal 2026 EPS results toward the lower end of the guidance range due to increased investments and cost headwinds.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Core earnings per share were $1.59, up 3% versus prior year; currency-neutral core EPS was $1.54, flat.
• All 10 product categories and 7 regions grew organic sales in the quarter.
• FY2026 guidance maintained: organic sales growth 0-4%, core EPS growth 0-4%, all-in EPS growth 1-6%.
• Company cited headwinds including tariffs ($0.4bn after-tax) and commodities ($0.15bn after-tax), with a $0.2bn FX tailwind.

7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• The dividend is payable on or after May 15, 2026, to shareholders of record at the close of business on April 24, 2026 (Common Stock) and at the start of business on April 24, 2026 (Preferred Stock).
• This represents a three percent increase compared to the prior quarterly dividend.
• P&G has paid a dividend for 136 consecutive years and has increased its dividend for 70 consecutive years.
• The disclosure was furnished under Item 7.01 Regulation FD, with the news release attached as Exhibit 99.1.

7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• Diluted EPS was $1.78, down 5%; core EPS was $1.88, flat versus prior year.
• Operating cash flow was $5.0 billion; adjusted free cash flow productivity was 88%.
• Company returned $4.8 billion to shareholders via dividends and share repurchases.
• Fiscal 2026 guidance: all-in sales growth 1-5%, organic sales growth in-line to up 4%, core EPS growth in-line to up 4% (range $6.83-$7.09).

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits